We are live on ! Find out more
IVM

InterWest Venture Management Portfolio holdings

AUM $20.6M
1-Year Est. Return 48.5%
This Fund
S&P 500
This Quarter Est. Return
-9.48%
1 Year Est. Return
+48.5%
3 Year Est. Return
-57.65%
5 Year Est. Return
-76.52%
10 Year Est. Return
–
AUM
$422M
AUM Growth
-$48M
Cap. Flow
+$69.2K
Cap. Flow %
0.02%
Top 10 Hldgs %
99.67%
Holding
12
New
–
Increased
2
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
TSRO
TESARO, Inc.
TSRO
+$48.5K
2
AGTC
Applied Genetic Technologies Corporation
AGTC
+$20.7K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TSRO
1
DELISTED
TESARO, Inc.
TSRO
$283M 66.95%
2,021,738
+335
+0% +$48.5K
GKOS icon
2
Glaukos
GKOS
$8.72B
$42.2M 10%
1,018,362
– –
HIND
3
Vyome Holdings
HIND
$14M
– –
0
– –
MGNX icon
4
MacroGenics
MGNX
$238M
$18.8M 4.45%
1,074,316
– –
EIGR
5
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$12.6M 2.99%
53,320
– –
PRTK
6
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$12.3M 2.92%
512,366
– –
CDTX
7
DELISTED
Cidara Therapeutics
CDTX
$10.2M 2.41%
67,841
– –
IVTY
8
DELISTED
Invuity, Inc
IVTY
$7.83M 1.85%
1,080,272
– –
AGTC
9
DELISTED
Applied Genetic Technologies Corporation
AGTC
$7.42M 1.76%
1,455,904
+3,688
+0.3% +$20.7K
KALV
10
DELISTED
KalVista Pharmaceuticals
KALV
$2.43M 0.57%
329,942
– –
LITS
11
Lite Strategy Inc
LITS
$33.2M
$1.39M 0.33%
29,020
– –
XENE icon
12
Xenon Pharmaceuticals
XENE
$6.27B
$26K 0.01%
8,293
– –

Similar funds

RCP
Rho Capital Partners New York $20.4M AUM
LUGPI
Lightspeed Ultimate General Partner IX Menlo Park, California $20.3M AUM 4.78% 1-Year Est. Return
SIC
Starr International Company Zug, Switzerland $19.9M AUM 39.69% 1-Year Est. Return
DOS
David O. Sacks $19.8M AUM 4.02% 1-Year Est. Return
AA
Antipodean Advisors New York $19.5M AUM 6.21% 1-Year Est. Return
CVSCT
C.V. Starr & Co Trust New York $19.4M AUM 28.57% 1-Year Est. Return
VNB
Virginia National Bank Charlottesville, Virginia $21.9M AUM 12.04% 1-Year Est. Return
BEP
Brookside Equity Partners Stamford, Connecticut $22.5M AUM 62.43% 1-Year Est. Return

InterWest Venture Management's Q2 2017 Portfolio in Review

As of Q2 2017, InterWest Venture Management held 12 positions worth $422M, down 10% from $470M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2017: portfolio turnover was 0%. InterWest Venture Management opened no new positions and made no exits, leaving the 12-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • InterWest Venture Management added most to TESARO, Inc. in Q2 2017, an estimated $48.5K increase.
  • InterWest Venture Management's ten largest holdings make up 100% of its $422M portfolio in Q2 2017.
  • InterWest Venture Management opened 0 new positions and closed 0 in Q2 2017.
  • InterWest Venture Management's portfolio value fell 10% quarter-over-quarter to $422M.

Based on InterWest Venture Management's 13F filing for Q2 2017, filed 11 Jul 2017.